Hypertension (HTN) is a major modifiable risk factor for cardiovascular disease (CVD)
morbidity and mortality. The left ventricle (LV) is a primary target for HTN end-organ damage …

Hypertension remains a major contributor to the global burden of disease. The
measurement of blood pressure continues to have pitfalls related to both physiological …

Three-dimensional (3D) echocardiographic (3DE) imaging represents a major innovation in
cardiovascular ultrasound. Advancements in computer and transducer technologies permit …

Cardiac dysfunction resulting from exposure to cancer therapeutics was first recognized in
the 1960s, with the widespread introduction of anthracyclines into the oncological …

Objectives: The primary aim of this systematic review is to objectively evaluate the test
performance characteristics of three-dimensional echocardiography (3DE) in measuring left …

Modern treatment strategies have led to improvements in cancer survival, however, these
gains might be offset by the potential negative effect of cancer therapy on cardiovascular …

Background and Methods In order to provide guidance for using measurements of left
ventricular (LV) volume and ejection fraction (LVEF) from different echocardiographic …

Objectives: We sought to study: 1) the accuracy and reproducibility of real-time 3-
dimensional echocardiographic (RT3DE) analysis of left ventricular (LV) volumes in a …

Background—Cardiac CT (CCT) and real-time 3D echocardiography (RT3DE) are being
used increasingly in clinical cardiology. CCT offers superb spatial and contrast resolution …

Echocardiography is well qualified to meet the growing need for noninvasive imaging in the
expanding heart failure (HF) population. The recently-released American College of …